You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MAT2A inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma Trial (Combination (S095033 + paclitaxel))

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Combination (S095033 + paclitaxel)
  • (no location specified)
Mar 28, 2022

Solid Tumor Trial in United States (IDE397, Docetaxel, Paclitaxel)

Recruiting
  • Solid Tumor
  • Scottsdale, Arizona
  • +10 more
Jul 20, 2022

Metastatic Colorectal Cancer Trial (LB-100, Azenosertib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Oct 31, 2023

Metastatic Microsatellite-stable Colorectal Cancer Trial (LB-100, Atezolizumab)

Not yet recruiting
  • Metastatic Microsatellite-stable Colorectal Cancer
  • (no location specified)
Sep 1, 2023

Candidiasis, Chronic Mucocutaneous Trial run by the Matinas BioPharma Nanotechnologies, Inc. (Amphotericin B)

Completed
  • Candidiasis, Chronic Mucocutaneous
  • Amphotericin B
  • Bethesda, Maryland
    National Institute of Allergy and Infectious Disease (NIAID)
Aug 17, 2022

Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

Not yet recruiting
  • Estrogen-receptor-positive Breast Cancer
  • +3 more
  • elacestrant, palbociclib, abemaciclib, ribociclib
  • Chicago, Illinois
    Northwestern University
Sep 25, 2023

Cardiorenal Syndrome Trial in New Haven (Dapagliflozin)

Not yet recruiting
  • Cardiorenal Syndrome
  • New Haven, Connecticut
    Yale New Haven Hospital
Oct 26, 2023

Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage

Recruiting
  • Advanced Solid Tumor
  • Refractory Tumor
  • Radiotherapy
  • +4 more
  • Suzhou, China
    The Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023

Cystic Fibrosis-related Diabetes, Cystic Fibrosis Trial in Minneapolis (Empagliflozin, Placebo Control)

Not yet recruiting
  • Cystic Fibrosis-related Diabetes
  • Cystic Fibrosis
  • Minneapolis, Minnesota
    University of Minnesota
Nov 20, 2023

Breast Cancer Trial in Guangzhou (Capecitabine, Aromatase Inhibitor)

Active, not recruiting
  • Breast Cancer
  • Guangzhou, Guangdong, China
    State Key Laboratory of Oncology in South China, Sun Yat-sen Uni
Jan 27, 2023

Lupus Nephritis, Chronic Kidney Diseases Trial in Hong Kong (Dapagliflozin 10mg Tab, Standard maintenance therapy)

Not yet recruiting
  • Lupus Nephritis
  • Chronic Kidney Diseases
  • Dapagliflozin 10mg Tab
  • Standard maintenance therapy
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Nov 24, 2023

Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)

Completed
  • Relapsed or Refractory Lymphoma
  • Itraconazole 200 mg
  • +3 more
  • Miami, Florida
    QPS- Miami
Jan 12, 2023

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

Multiple Sclerosis Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (tolebrutinib 60mg,

Active, not recruiting
  • Multiple Sclerosis
  • tolebrutinib 60mg
  • tolebrutinib 120mg
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,

Completed
  • Gastrointestinal Tumor
  • Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
  • tislelizumab (BeiGene, China) combined with PD-1 inhibitor
  • Hangzhou, China
    Zhejiang Hospital
Sep 1, 2023

Healthy Adults Trial in Dallas (Treatment A, Treatment B)

Not yet recruiting
  • Healthy Adults
  • Treatment A
  • Treatment B
  • Dallas, Texas
    Labcorp Clinical Research Unit Inc
May 11, 2023

Compare Overall Survival in Medicare Metastatic Breast Cancer

Active, not recruiting
  • Breast Cancer
  • New York, New York
    Pfizer New York
Oct 11, 2023

Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals

Not yet recruiting
  • Preterm Labor
    • (no location specified)
    May 9, 2023

    Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

    Recruiting
    • Astrocytoma, Grades II, III and IV
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    Severe Aplastic Anemia, Single Lineage Cytopenias, T-LGL, Hypoplastic MDS Trial run by the National Heart, Lung, and Blood

    Not yet recruiting
    • Severe Aplastic Anemia
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 23, 2023

    Head Neck Cancer, Intratumoral Injection Trial in Chicago (RiMO-301)

    Recruiting
    • Head Neck Cancer
    • Intratumoral Injection
    • Chicago, Illinois
      University of Illinois at Chicago
    Apr 28, 2023

    Metabolic Associated Fatty Liver Disease Trial (dapagliflozin (Forxiga))

    Not yet recruiting
    • Metabolic Associated Fatty Liver Disease
    • dapagliflozin (Forxiga)
    • (no location specified)
    Mar 13, 2023

    Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

    Not yet recruiting
    • Myelofibrosis
    • Moderate Thrombocytopenia
    • (no location specified)
    Jul 31, 2023

    Healthy Volunteers Trial run by the NIDDK (Placebo, Canagliflozin)

    Completed
    • Healthy Volunteers
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Advanced Solid Tumor Trial (INCB099280)

    Not yet recruiting
    • Advanced Solid Tumor
    • (no location specified)
    May 19, 2023